NOS3 and prostate neoplasm: A Re et al. shows that a combinatorial complex between estrogen receptor (ER)-β and endothelial nitric oxide synthase (eNOS) could repress transcription of prognostic genes that are down-regulated in prostate tumors, such as the glutathione transferase gene GSTP1 (Re et al., 2011).